Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Frazier Management
AddedFeb 13, 2024
UpdatedJul 16, 2026
Frazier Management

Frazier Management

Operating

Frazier Healthcare Partners: A dedicated healthcare private equity and venture capital firm for 25 years.

Location
Seattle, WA, US
Founded
1991
Firm
Compare
Portfolio
Employees
Website

Frazier Healthcare Partners focuses on healthcare investments, with two distinct strategies. Their Growth Buyout arm targets profitable US middle-market healthcare businesses, while Frazier Life Sciences invests in private and public companies developing innovative biopharmaceuticals. The firm's investment sizes vary, with a strong presence in early to mid-stage rounds.

Notable portfolio companies include Amicus Therapeutics, AnaptysBio, and Gritstone bio. Frazier Healthcare Partners has a 25-year track record in healthcare investing, demonstrating deep sector expertise. The firm's approach combines capital investment with industry knowledge to support transformative healthcare companies, positioning itself as a trusted partner in the healthcare ecosystem.

Frazier Management - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments84
Current Portfolio Count50
Total Portfolio Exits3

Top Investment Stages

Series A23 (33.3%)
Series B21 (30.4%)
Post Ipo Equity10 (14.5%)
Series Unknown8 (11.6%)
Series C7 (10.1%)

Stage Mix

Series A 33%Series B 30%Post Ipo Equity 14%Series Unknown 12%Series C 10%

Concentration shown as share of disclosed investments by stage.

Recent Investments

CurveBeam logo

CurveBeam

Metagenomi logo

Metagenomi

Silence Therapeutics logo

Silence Therapeutics

Radionetics Oncology logo

Radionetics Oncology

Gritstone bio logo

Gritstone bio

Alpine Immune Sciences logo

Alpine Immune Sciences

Sonoma Biotherapeutics logo

Sonoma Biotherapeutics

Crinetics Pharmaceuticals logo

Crinetics Pharmaceuticals

Seraxis logo

Seraxis

Aclaris Therapeutics logo

Aclaris Therapeutics

Sutro Biopharma logo

Sutro Biopharma

Inipharm logo

Inipharm

MBX Biosciences logo

MBX Biosciences

Lassen Therapeutics logo

Lassen Therapeutics

Dascena logo

Dascena

Aspen Neuroscience logo

Aspen Neuroscience

Molecular Templates logo

Molecular Templates

Syndax Pharmaceuticals logo

Syndax Pharmaceuticals

Tarsus Pharmaceuticals logo

Tarsus Pharmaceuticals

Regenxbio logo

Regenxbio

Arcutis Biotherapeutics logo

Arcutis Biotherapeutics

Recida Therapeutics logo

Recida Therapeutics

Sojournix logo

Sojournix

Mirum Pharmaceuticals logo

Mirum Pharmaceuticals

Cirius Therapeutics logo

Cirius Therapeutics

Frazier Management - Similar Investment Firms

Enhanced Healthcare Partners logo

Enhanced Healthcare Partners

Frazier Technology Ventures logo

Frazier Technology Ventures

Francisco Partners logo

Francisco Partners

Alliance Healthcare Partners logo

Alliance Healthcare Partners

Zaffre Investments logo

Zaffre Investments

FFL Partners logo

FFL Partners

fflpartners.com

Amicus Capital Partners logo

Amicus Capital Partners

DW Healthcare Partners logo

DW Healthcare Partners

dwhp.com

Frist Cressey Ventures logo

Frist Cressey Ventures

fcventures.com

Venrock Healthcare Capital Partners logo

Venrock Healthcare Capital Partners

Healthcare Ventures logo

Healthcare Ventures

hcven.com

Health Enterprise Partners logo

Health Enterprise Partners

hepfund.com

RoundTable Healthcare Partners logo

RoundTable Healthcare Partners

roundtablehp.com

Health2047 Capital Partners logo

Health2047 Capital Partners

Varsity Healthcare Partners logo

Varsity Healthcare Partners

Frazier Management - Classification

Also Known As
  • Frazier Management LLC
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end